Kelleher Financial Advisors’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-3,600
Closed -$283K 140
2016
Q4
$283K Buy
+3,600
New +$280K 0.16% 106
2016
Q3
Sell
-3,600
Closed -$247K 152
2016
Q2
$247K Buy
+3,600
New +$248K 0.15% 109
2016
Q1
Sell
-7,200
Closed -$223K 235
2015
Q4
$223K Hold
7,200
0.15% 99
2015
Q3
$375K Buy
7,200
+3,600
+100% +$191K 0.25% 79
2015
Q2
$193K Hold
3,600
0.11% 109
2015
Q1
$171K Hold
3,600
0.09% 112
2014
Q4
$156K Hold
3,600
0.08% 107
2014
Q3
$124K Hold
3,600
0.07% 107
2014
Q2
$132K Hold
3,600
0.07% 104
2014
Q1
$121K Hold
3,600
0.07% 102
2013
Q4
$114K Hold
3,600
0.06% 100
2013
Q3
$115K Hold
3,600
0.07% 99
2013
Q2
$81K Buy
+3,600
New +$77.9K 0.05% 98

Other funds holding CMD

Kelleher Financial Advisors's CMD Position: Q1 2017 in Review

Kelleher Financial Advisors sold out of Cantel Medical Corporation (CMD) in Q1 2017, closing a stake of 3,600 shares — an estimated $283K sold.

Kelleher Financial Advisors first reported a position in CMD in Q2 2013 and held it in 13 quarters. The position peaked at $375K in Q3 2015. 218 funds tracked by Wall St. Rank hold CMD as of Q1 2017.

  • Kelleher Financial Advisors reported no remaining Cantel Medical Corporation position as of Q1 2017 after selling out during the quarter.
  • Kelleher Financial Advisors sold 3,600 Cantel Medical Corporation shares in Q1 2017, an estimated $283K.
  • Kelleher Financial Advisors first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 13 quarters.
  • Kelleher Financial Advisors's Cantel Medical Corporation position peaked at $375K in Q3 2015.
  • 218 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2017.

Based on Kelleher Financial Advisors's 13F filing for Q1 2017, filed 12 May 2017.